SB192
To Amend the Law Concerning Coverage of Biosimlar Medical Products Under Step Therapy Protocols; and to Amend Exceptions to Step Therapy Protocols.
View official title
TO AMEND THE LAW CONCERNING COVERAGE OF BIOSIMLAR MEDICAL PRODUCTS UNDER STEP THERAPY PROTOCOLS; AND TO AMEND EXCEPTIONS TO STEP THERAPY PROTOCOLS.
Log in to follow this bill and get alerts.
Said about this bill
House Convenes
Matched: “SB192 J. Boyd Achor TO AMEND THE LAW CONCERNING COVERAGE OF BIOSI…”
Insurance & Commerce- House
Matched: “…RE FAIRNESS TO ALL RATEPAYERS; AND TO DECLARE AN EMERGENCY. SB192 J. Boyd TO AMEND THE LAW CONCERNING COVERAGE OF BIOSIMLAR M…”
Senate Convenes
Matched: “SB192 J. Boyd TO AMEND THE LAW CONCERNING COVERAGE OF BIOSIMLAR M…”
Insurance & Commerce - Senate
Matched: “…MBER 31, 2022, TO RESIDENTIAL BUILDING CONTRACTOR LICENSES. SB192 J. Boyd TO AMEND THE LAW CONCERNING COVERAGE OF BIOSIMLAR M…”
Documents (2)
- Agenda — INSURANCE & COMMERCE- HOUSE, Feb 15, 2023 · Feb. 15, 2023
- Agenda — INSURANCE & COMMERCE - SENATE, Feb 7, 2023 · Feb. 7, 2023